Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VEGFR ADP GLO Assay from US Patent US20240109917: "PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS"
Assay data:23 Active, 13 Activity ≤ 1 µM, 485 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
PDGFRβ LanthaScreen Assay from US Patent US20240109917: "PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS"
Assay data:478 Active, 11 Activity ≤ 1 nM, 468 Activity ≤ 1 µM, 485 Tested
PDGFRβ HTRF Assay from US Patent US20240109917: "PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS"
Assay data:485 Active, 377 Activity ≤ 1 nM, 483 Activity ≤ 1 µM, 485 Tested
In Vitro CDK7 Assay from US Patent US20240109912: "TRICYCLIC PYRIMIDINES AS CYCLIN-DEPENDENT KINASE 7 (CDK7) INHIBITORS"
Assay data:135 Active, 110 Activity ≤ 1 nM, 131 Activity ≤ 1 µM, 135 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Activity Inhibition Assay on CDK Family Kinases from US Patent US20240109898: "SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE DERIVATIVES, COMPOSITIONS AND PHARMACEUTICAL USES THEREOF"
Assay data:84 Active, 83 Activity ≤ 1 µM, 84 Tested
ADP-Glo Kinase Assay from US Patent US20240109890: "BRIDGED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE COMPOUNDS, PREPARATION METHOD AND MEDICAL USE THEREOF"
Assay data:6 Active, 6 Activity ≤ 1 µM, 6 Tested
Electrophoretic Mobility Shift Assay (MSA) from US Patent US20240109877: "PYRIMIDINES FOR DEGRADING BRUTON'S TYROSINE KINASE"
Assay data:19 Active, 19 Activity ≤ 1 nM, 19 Activity ≤ 1 µM, 19 Tested
Kinase Assay from US Patent US20240109865: "INDAZOLE COMPOUNDS AS KINASE INHIBITORS"
Assay data:359 Active, 363 Activity ≤ 1 µM, 363 Tested
JAK2 Z-Lyte Biochemical Assay from US Patent US20240101559: "TRICYCLIC KINASE INHIBITORS AND USES THEREOF"
Assay data:9 Active, 1 Activity ≤ 1 µM, 11 Tested
Inhibition Activity of Compounds of the Present Invention on TYK2 JH2 Domain from US Patent US20240101548: "HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF"
Assay data:20 Active, 20 Activity ≤ 1 nM, 20 Activity ≤ 1 µM, 20 Tested
ADP-Glo Kinase Assay from US Patent US20240101538: "PROTEIN-PROTEIN INTERACTION MODULATORS OF AURORA KINASE A AND THEIR USE IN THE PREVENTION AND/OR TREATMENT OF CANCER"
Assay data:3 Active, 3 Activity ≤ 1 µM, 10 Tested
ABL1 Biochemical Kinase Assay from US Patent US20240101536: "COMPOUNDS FOR TREATING CERTAIN LEUKEMIAS"
Assay data:217 Active, 190 Activity ≤ 1 nM, 217 Activity ≤ 1 µM, 217 Tested
MNK Biochemical Enzymatic Assay from US Patent US20240092799: "MNK INHIBITORS"
Assay data:156 Active, 169 Activity ≤ 1 µM, 169 Tested
Measurement of CSF1R Kinase Activity from US Patent US20240092774: "HETEROAROMATIC COMPOUNDS AND USES THEREOF"
Assay data:86 Active, 86 Activity ≤ 1 µM, 86 Tested
CDK2/Cyclin E1 Full Length ADP-Glo Kinase Assay from US Patent US20240092761: "QUINAZOLINE COMPOUNDS AND METHODS OF USE"
Assay data:111 Active, 104 Activity ≤ 1 µM, 122 Tested
CDK1/Cyclin B1 ADP-Glo Kinase Assay from US Patent US20240092761: "QUINAZOLINE COMPOUNDS AND METHODS OF USE"
Assay data:83 Active, 59 Activity ≤ 1 µM, 122 Tested
Biochemical JAK Kinase Assays from US Patent US20240092758: "IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS"
Assay data:392 Active, 381 Activity ≤ 1 nM, 392 Activity ≤ 1 µM, 392 Tested
CK2 Alpha 1 Enzymatic Activity Inhibition from US Patent US11932606: "Anti-cancer/anti-fibrosis compounds"
Assay data:34 Active, 29 Activity ≤ 1 µM, 34 Tested
In Vitro BTK Kinase Assay: Btk-PolyGAT-LS Assay from US Patent US20240083900: "PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS"
Assay data:228 Active, 80 Activity ≤ 1 nM, 228 Activity ≤ 1 µM, 228 Tested
Biochemical Assay for Modulation (Inhibition/Activation) of GCN2 from US Patent US20240083897: "GCN2 MODULATING COMPOUNDS AND USES THEREOF"
Assay data:203 Active, 208 Activity ≤ 1 µM, 208 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on